Hedge Fund - Knoll Capital Management
Eiger Biopharmaceuticals Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $ |
| 2 | 2022 - Q3 (2022-09-30) | $586,000 | 0.34% | 585,966 | $ |
| 3 | 2022 - Q2 (2022-06-30) | $4,374,000 | 2.49% | 694,232 | $ |
| 4 | 2022 - Q1 (2022-03-31) | $5,762,000 | 3.61% | 694,232 | $ |
| 5 | 2021 - Q4 (2021-12-31) | $3,603,000 | 1.97% | 694,232 | $ |
| 6 | 2021 - Q3 (2021-09-30) | $4,637,000 | 2.31% | 694,232 | $ |
| 7 | 2021 - Q2 (2021-06-30) | $5,915,000 | 3.08% | 694,232 | $ |
| 8 | 2021 - Q1 (2021-03-31) | $6,144,000 | 4% | 694,232 | $ |
| 9 | 2020 - Q4 (2020-12-31) | $8,532,000 | 5.81% | 694,232 | $ |
| 10 | 2020 - Q3 (2020-09-30) | $4,845,000 | 3.97% | 595,238 | $ |
| 11 | 2020 - Q2 (2020-06-30) | $5,063,000 | 2.92% | 525,238 | $ |
| 12 | 2020 - Q1 (2020-03-31) | $3,232,000 | 3.03% | 475,238 | $ |
| 13 | 2019 - Q4 (2019-12-31) | $5,219,000 | 3.85% | 350,238 | $ |
| 14 | 2019 - Q3 (2019-09-30) | $3,590,000 | 3.28% | 350,238 | $ |
| 15 | 2019 - Q2 (2019-06-30) | $3,713,000 | 3.03% | 350,238 | $ |
| 16 | 2019 - Q1 (2019-03-31) | $1,052,000 | 0.79% | 75,238 | $ |
| 17 | 2018 - Q4 (2018-12-31) | $764,000 | 0.86% | 75,238 | $ |
| 18 | 2018 - Q3 (2018-09-30) | $910,000 | 0.76% | 75,238 | $ |
| 19 | 2018 - Q2 (2018-06-30) | $918,000 | 0.78% | 75,238 | $ |
| 20 | 2018 - Q1 (2018-03-31) | $741,000 | 0.76% | 75,238 | $ |
The displayed share prices are average quarterly stock market prices.